The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression

Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the ro...

Full description

Bibliographic Details
Published in:Cell Death and Disease
Main Authors: Long Gao, Yuan Liu, Xiaohong Du, Sai Ma, Minmin Ge, Haijun Tang, Chenfeng Han, Xin Zhao, Yanbin Liu, Yun Shao, Zhao Wu, Lianjun Zhang, Fang Meng, F. Xiao-Feng Qin
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Online Access:https://doi.org/10.1038/s41419-021-03968-2
_version_ 1852801250268020736
author Long Gao
Yuan Liu
Xiaohong Du
Sai Ma
Minmin Ge
Haijun Tang
Chenfeng Han
Xin Zhao
Yanbin Liu
Yun Shao
Zhao Wu
Lianjun Zhang
Fang Meng
F. Xiao-Feng Qin
author_facet Long Gao
Yuan Liu
Xiaohong Du
Sai Ma
Minmin Ge
Haijun Tang
Chenfeng Han
Xin Zhao
Yanbin Liu
Yun Shao
Zhao Wu
Lianjun Zhang
Fang Meng
F. Xiao-Feng Qin
author_sort Long Gao
collection DOAJ
container_title Cell Death and Disease
description Abstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the role of tumor expressed-CD38 on neoplastic formation and progression remains elusive. In the present study, we aimed to delineate the molecular and biochemical function of the tumor-associated CD38 in lung adenocarcinoma progression. Our clinical data showed that the upregulation of tumor-originated CD38 was correlated with poor survival of lung cancer patients. Using multiple in vitro assays we found that the enzymatic activity of tumor expressed-CD38 facilitated lung cancer cell migration, proliferation, colony formation, and tumor development. Consistently, our in vivo results showed that inhibition of the enzymatic activity or antagonizing the enzymatic product of CD38 resulted in the similar inhibition of tumor proliferation and metastasis as CD38 gene knock-out or mutation. At biochemical level, we further identified that cADPR, the mainly hydrolytic product of CD38, was responsible for inducing the opening of TRPM2 iron channel leading to the influx of intracellular Ca2+ and then led to increasing levels of NRF2 while decreasing expression of KEAP1 in lung cancer cells. These findings suggested that malignant lung cancer cells were capable of using cADPR catalyzed by CD38 to facilitate tumor progression, and blocking the enzymatic activity of CD38 could be represented as an important strategy for preventing tumor progression.
format Article
id doaj-art-a4e348d88b4e4e2b82f234dcd0f031e5
institution Directory of Open Access Journals
issn 2041-4889
language English
publishDate 2021-07-01
publisher Nature Publishing Group
record_format Article
spelling doaj-art-a4e348d88b4e4e2b82f234dcd0f031e52025-08-19T20:39:56ZengNature Publishing GroupCell Death and Disease2041-48892021-07-0112711310.1038/s41419-021-03968-2The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progressionLong Gao0Yuan Liu1Xiaohong Du2Sai Ma3Minmin Ge4Haijun Tang5Chenfeng Han6Xin Zhao7Yanbin Liu8Yun Shao9Zhao Wu10Lianjun Zhang11Fang Meng12F. Xiao-Feng Qin13Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Clinical Medicine Research, the Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Science and Technology Town HospitalInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeInstitute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract It has been recently reported that CD38 expressed on tumor cells of multiple murine and human origins could be upregulated in response to PD-L1 antibody therapy, which led to dysfunction of tumor-infiltrating CD8+ T immune cells due to increasing the production of adenosine. However, the role of tumor expressed-CD38 on neoplastic formation and progression remains elusive. In the present study, we aimed to delineate the molecular and biochemical function of the tumor-associated CD38 in lung adenocarcinoma progression. Our clinical data showed that the upregulation of tumor-originated CD38 was correlated with poor survival of lung cancer patients. Using multiple in vitro assays we found that the enzymatic activity of tumor expressed-CD38 facilitated lung cancer cell migration, proliferation, colony formation, and tumor development. Consistently, our in vivo results showed that inhibition of the enzymatic activity or antagonizing the enzymatic product of CD38 resulted in the similar inhibition of tumor proliferation and metastasis as CD38 gene knock-out or mutation. At biochemical level, we further identified that cADPR, the mainly hydrolytic product of CD38, was responsible for inducing the opening of TRPM2 iron channel leading to the influx of intracellular Ca2+ and then led to increasing levels of NRF2 while decreasing expression of KEAP1 in lung cancer cells. These findings suggested that malignant lung cancer cells were capable of using cADPR catalyzed by CD38 to facilitate tumor progression, and blocking the enzymatic activity of CD38 could be represented as an important strategy for preventing tumor progression.https://doi.org/10.1038/s41419-021-03968-2
spellingShingle Long Gao
Yuan Liu
Xiaohong Du
Sai Ma
Minmin Ge
Haijun Tang
Chenfeng Han
Xin Zhao
Yanbin Liu
Yun Shao
Zhao Wu
Lianjun Zhang
Fang Meng
F. Xiao-Feng Qin
The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title_full The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title_fullStr The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title_full_unstemmed The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title_short The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression
title_sort intrinsic role and mechanism of tumor expressed cd38 on lung adenocarcinoma progression
url https://doi.org/10.1038/s41419-021-03968-2
work_keys_str_mv AT longgao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yuanliu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT xiaohongdu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT saima theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT minminge theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT haijuntang theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT chenfenghan theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT xinzhao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yanbinliu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yunshao theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT zhaowu theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT lianjunzhang theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT fangmeng theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT fxiaofengqin theintrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT longgao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yuanliu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT xiaohongdu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT saima intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT minminge intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT haijuntang intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT chenfenghan intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT xinzhao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yanbinliu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT yunshao intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT zhaowu intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT lianjunzhang intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT fangmeng intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression
AT fxiaofengqin intrinsicroleandmechanismoftumorexpressedcd38onlungadenocarcinomaprogression